Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection; Discovery of Pibrentasvir, a pan-genotype HCV NS5A inhibitor with a high barrier to viral resistance

Speaker: 
Dr. John Randolph, Sr. Principal Research Scientist, CMeC, Abbvie, Inc.
Location: 
RHPH 164
Date / Time: 
Thursday, September 26, 2019 - 4:00pm
Host: 
Dr. Jo. V. Davisson

Mega Menu Visual Content